Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Imipenem
by Most Patent Filings in the China in 2018

The Imipenem top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filings Imipenem Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Imipenem (Primaxin among others) is an intravenous β-lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in the mid-1970s. Carbapenems are highly resistant to the β-lactamase enzymes produced by many multiple drug-resistant Gram-negative bacteria, thus play a key role in the treatment of infections not readily treated with other antibiotics.
#
Company Name
Region
Tech Topics
Total
1
Patent: 8
2
Patent: 4
3
Asymchem Laboratories (Tianjin) Co., Ltd.
Patent: 3
4
Contract Manufacturing
Patent: 3
5
Patent: 3
6
Patent: 2
7
Patent: 2
8
Patent: 2
9
Patent: 2
10
Health care,Drugs production,Drug,
...[+2]
Patent: 1
11
Drug,Health care,Buspirone,
...[+2]
Patent: 1
12
Patent: 1
13
Fine chemical,Excipient,Health care,
...[+2]
Patent: 1
14
Medicine,Health care,Excipient,
...[+2]
Patent: 1
15
Patent: 1
16
Patent: 1
17
Patent: 1
18
Patent: 1
19
Health care,Research system,International health,
...[+2]
Patent: 1
20
Patent: 1
Page generation time: Apr 27 2025